Mylin Torres, MD, talks with Prof. Dr. med. Guido Hildebrandt about the secondary results of the INSEMA trial, which evaluated applied radiotherapy among patients undergoing breast-conserving surgery with or without axillary sentinel lymph node biopsy.
Estimated Read Time:
1 minute
SABCS Snippets: Results of the INSEMA Trial
Share
Recent Posts
-
December 15, 2025
-
December 15, 2025
-
FDA session offers closer look at approval process for HR-positive metastatic breast cancer therapies
December 15, 2025 -
December 15, 2025
